Amgen Inc. (NASDAQ:AMGN)’s thrombocytopenia drug Nplate (romiplostim) showed significant benefits in a Phase III trial for ...

Nplate improved platelet response and reduced therapy modification for patients with chemotherapy-induced thrombocytopaenia.

Community oncology faces significant challenges from the Inflation Reduction Act's (IRA) drug pricing changes, risking ...

Amgen's Nplate proves highly effective in preventing thrombocytopenia from chemotherapy, enabling full-dose cancer treatment ...

Amgen's Nplate, which treats low blood platelet counts caused by an autoimmune condition, was highly effective at preventing ...

Explore growth drivers, innovations, and future trends shaping the Thrombocytopenia Treatment Market from 2025 to 2035 Thrombocytopenia treatment market to witness transformative growth driven by ...

Nplate (romiplostim) is a brand-name injection that’s prescribed for thrombocytopenia in certain adults and children. The cost of the drug with and without insurance may depend on whether Nplate ...

Nplate (romiplostim) injection is a prescription drug that’s used to treat low platelet counts. Nplate’s cost may depend on factors such as your dosage, whether you have health insurance ...

Purpose: The pharmacology, pharmacokinetics, dosage and administration, efficacy, safety, effects on quality of life, and place in therapy of romiplostim are reviewed. Summary: Romiplostim is a ...

Review the side-effects of Romiplostim as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of ...

Nplate (romiplostim) is a brand-name subcutaneous injection that’s prescribed to increase platelet levels (platelets are cells that help form blood clots) in certain situations. Nplate is not ...